Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs propofol induction for valve surgery hemodynamics
ChiCTR2200059378Phase 4Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Apr 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Cardiac valve disease (VHD) comparing Ciprofol induction with Propofol induction (2 arms). Primary endpoint: Incidence of post-induction hypotension. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR2200059378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059378.